The current invention refers to cucumbers, nucleic acids and cells for immunotherapy. Specifically, the current invention is immunotherapy for cancer. In addition, the present invention also refers to the cortex inflammation of lymphocyte T-cell toxicology (CTL) related to tumor, which is used alone or in combination with other cortex inflammation related to tumor. These cortex inflammation are the effective pharmacology principle of vaccine composition and can stimulate the immune response against tumor. More specifically, the invention refers to bass, which includes chemical abstract number: 5 or sequence, 80% of the approved variables.La presente invencion se refiere a peptidos, acidos nucleicos y celulas para la utilizacion en metodos inmunoterapeuticos. En concreto, la presente invencion se refiere a la inmunoterapia contra el cancer. La presente invencion se refiere, ademas, a epitopos peptidicos de linfocitos T citotoxicos (CTL) asociados a tumor, solos o en combinacion con otros peptidos asociados a tumor que sirven como principios activos farmaceuticos de composiciones vacunales que estimulan respuestas inmunitarias antitumorales. Mas especificamente, la invencion se refiere a peptidos que comprenden la SEQ ID NO: 5 o secuencias variantes homologas en un 80% a esta
